Circular 9 of 2022 Inspection of Premises prior to renewal of Licences and Permits

Medicines Control Authority of Zimbabwe Follow

Medicines Control Authority of Zimbabwe @mcazofficial ·

22h

#HappyIndependenceDay MCAZ joins the nation in celebrating 44 years of independence.

#Zim44 #ZimAt44

Reply on Twitter 1780822379502923996 Retweet on Twitter 1780822379502923996 3 Like on Twitter 1780822379502923996 18 Twitter 1780822379502923996

Medicines Control Authority of Zimbabwe @mcazofficial ·

15 Apr

1/🚨[READ] The MCAZ would like to inform all stakeholders of a critical communication from the National Agency for Food and Drug Administration (NAFDAC) of Nigeria regarding the recall of Benylin Paediatric 100ml Syrup.

For more information https://www.mcaz.co.zw/wp-content/uploads/2024/04/MEDIA-RELEASE-Benylin-Recall-Statement.pdf

Reply on Twitter 1779885113418842144 Retweet on Twitter 1779885113418842144 15 Like on Twitter 1779885113418842144 11 Twitter 1779885113418842144

Medicines Control Authority of Zimbabwe @mcazofficial ·

9 Apr

1/ The Authority invites Medicines and Medical products registration applicants and other relevant stakeholders to participate in a virtual meeting titled "MCAZ feedback on the new system of processing applications for registration. - Circular 26 of 2023."

Reply on Twitter 1777708978480329105 Retweet on Twitter 1777708978480329105 2 Like on Twitter 1777708978480329105 4 Twitter 1777708978480329105

Medicines Control Authority of Zimbabwe @mcazofficial ·

8 Apr

1/ As part of the Authority’s continued enforcement activities aimed at identified hotspots where individuals involved in the illegal distribution of unregistered medicines, expired drugs, and other illicit medicinal products conduct their business,

Reply on Twitter 1777328984138670458 Retweet on Twitter 1777328984138670458 8 Like on Twitter 1777328984138670458 22 Twitter 1777328984138670458

Circular 9 of 2022 Inspection of Premises prior to renewal of Licences and Permits

QUICK LINKS

FACEBOOK FEED

TWITTER FEED

CONTACT US